Human CNS cultures exposed to HIV-I gp120 reproduce dendritic injuries of HIV-I-associated dementia

Journal of Neuroinflammation

Volumn 1, Issue , 2004, Pages

  Iskander, Sam ^a   Walsh, Kimberley A ^a   Hammond, Robert R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; MICROTUBULE ASSOCIATED PROTEIN 2; SYNAPTOPHYSIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; AUTOPSY; BRAIN DEGENERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEMENTIA; DENDRITIC CELL; DISEASE ASSOCIATION; FETUS; GLIOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; NERVE CELL LESION; RISK FACTOR; TISSUE CULTURE; VIRUS CELL INTERACTION;

EID: 4344588900     PISSN: 17422094     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-2094-1-7     Document Type: Article

References (45)

1. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I: Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 1997, 54:416-424.
2. Clifford DB: Human immunodeficiency virus-associated dementia. Arch Neurol 2000, 57:321-324.
3. Kaul M, Garden GA, Lipton SA: Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
4. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L: HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002, 8:136-142.
5. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP: Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993, 43:2245-2252.
6. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ: Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999, 13:1249-1253.
7. Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J: Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 1998, 12:F65-F70.
8. Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Selnes OA, Becker JT, Cohen B, Wesch J, Miller EN: Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999, 52:1640-1647.
9. Major EO, Rausch D, Marra C, Clifford D: HIV-associated dementia. Science 2000, 288:440-442.
10. Lipton SA: Treating AIDS dementia. Science 1997, 276:1629-1630.
11. Walsh K, Thompson W, Megyesi J, Wiley CA, Hammond R: HIV-/AIDS Neuropathology in a canadian teaching centre. Can J Neurol Sci 2003,] in press:.
12. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA: Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 1992, 51:585-593.
13. Everall IP, Glass JD, McArthur J, Spargo E, Lantos P: Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol (Berl) 1994, 88:538-544.
14. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992, 32:321-329.
15. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E: Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 1999, 9:209-217.
16. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA: HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990, 248:364-367.
17. Kaiser PK, Offermann JT, Lipton SA: Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology 1990, 40:1757-1761.
18. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB: Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991, 7:111-118.
19. Catani MV, Corasaniti MT, Navarra M, Nistico G, Finazzi-Agro A, Melino G: gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem 2000, 74:2373-2379.
20. Kaul M, Lipton SA: Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 1999, 96:8212-8216.
21. Pandey V, Bolsover SR: Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 receptor. Biochem Biophys Res Commun 2000, 274:212-215.
22. Catani MV, Corasaniti MT, Ranalli M, Amantea D, Litovchick A, Lapidot A, Melino G: The Tat antagonist neomycin B hexa-arginine conjugate inhibits gp-120-induced death of human neuroblastoma cells. J Neurochem 2003, 84:1237-1245.
23. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD: Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 2000, 47:186-194.
24. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C: HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998, 4:1182-1184.
25. Zemlyak I, Brooke SM, Sapolsky RM: Protection against gp120-induced neurotoxicity by an array of estrogenic steroids. Brain Res 2002, 958:272-276.
26. Brooke SM, Sapolsky RM: Effects of glucocorticoids in the gp120-induced inhibition of glutamate uptake in hippocampal cultures. Brain Res 2003, 972:137-141.
27. Scorziello A, Florio T, Bajetto A, Schettini G: Intracellular signalling mediating HIV-1 gp120 neurotoxicity. Cell Signal 1998, 10:75-84.
28. Bruce-Keller AJ: Microglial-neuronal interactions in synaptic damage and recovery. J Neurosci Res 1999, 58:191-201.
29. Giulian D, Vaca K, Noonan CA: Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990, 250:1593-1596.
30. Giulian D, Wendt E, Vaca K, Noonan CA: The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A 1993, 90:2769-2773.
31. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK: Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992, 149:2736-2741.
32. Boje KM, Arora PK: Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992, 587:250-256.
33. Brooke SM, Sapolsky RM: Glucocorticoid exacerbation of gp120 neurotoxicity: role of microglia. Exp Neurol 2002, 177:151-158.
34. Dugas N, Lacroix C, Kilchherr E, Delfraissy JF, Tardieu M: Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. 2001, 15:96-107.
35. Pozzoli G, Tringali G, Dello Russo C., Vairano M, Preziosi P, Navarra P: HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase. J Neuroimmunol 2001, 118:268-276.
36. Howard SA, Nakayama AY, Brooke SM, Sapolsky RM: Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures. Exp Neurol 1999, 158:164-170.
37. Brandimarti R, Khan MZ, Fatatis A, Meucci O: Regulation of cell cycle proteins by chemokine receptors: A novel pathway in human immunodeficiency virus neuropathogenesis? J Neurovirol 2004, 10 Suppl 1):108-112.
38. Hammond RR, Iskander S, Achim CL, Hearn S, Nassif J, Wiley CA: A reliable primary human CNS culture protocol for morphological studies of dendritic and synaptic elements. J Neurosci Methods 2002, 118:189-198.
39. Martin FC, Wiley CA: A serum-free, pyruvate-free medium that supports neonatal neural/glial cultures. J Neurosci Res 1995, 41:246-258.
40. White MG, Hammond RR, Sanders VJ, Bonaroti EA, Mehta AP, Wang G, Wiley CA, Achim CL: Neuron-enriched second trimester human cultures: growth factor response and in vivo graft survival. Cell Transplant 1999, 8:59-73.
41. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I: Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997, 42:963-972.
42. McArthur JC, Sacktor N, Selnes O: Human immunodeficiency virus-associated dementia. Semin Neurol 1999, 19:129-150.
43. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu M, Gray F: Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999, 25:123-133.
44. Dawson VL, Dawson TM, Uhl GR, Snyder SH: Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A 1993, 90:3256-3259.
45. Cai L, Cherian MG, Iskander S, Leblanc M, Hammond RR: Metallothionein induction in human CNS in vitro: neuroprotection from ionizing radiation. Int J Radiat Biol 2000, 76:1009-1017.